153 related articles for article (PubMed ID: 32474013)
1. Urinary protein biomarkers for pediatric medulloblastoma.
Hao X; Guo Z; Sun H; Liu X; Zhang Y; Zhang L; Sun W; Tian Y
J Proteomics; 2020 Aug; 225():103832. PubMed ID: 32474013
[TBL] [Abstract][Full Text] [Related]
2. Zinc α2-glycoprotein as a potential novel urine biomarker for the early diagnosis of prostate cancer.
Katafigiotis I; Tyritzis SI; Stravodimos KG; Alamanis C; Pavlakis K; Vlahou A; Makridakis M; Katafigioti A; Garbis SD; Constantinides CA
BJU Int; 2012 Dec; 110(11 Pt B):E688-93. PubMed ID: 23020913
[TBL] [Abstract][Full Text] [Related]
3. Proteomic Profiling of Cryoglobulinemia.
Liu P; Wu J; Sun D; Li H; Qi Z; Tang X; Su W; Li Y; Qin X
Front Immunol; 2022; 13():855513. PubMed ID: 35677050
[TBL] [Abstract][Full Text] [Related]
4. A circulating extracellular vesicles-based novel screening tool for colorectal cancer revealed by shotgun and data-independent acquisition mass spectrometry.
Zheng X; Xu K; Zhou B; Chen T; Huang Y; Li Q; Wen F; Ge W; Wang J; Yu S; Sun L; Zhu L; Liu W; Gao H; Yue L; Cai X; Zhang Q; Ruan G; Zhu T; Wu Z; Zhu Y; Shao Y; Guo T; Zheng S
J Extracell Vesicles; 2020; 9(1):1750202. PubMed ID: 32363013
[No Abstract] [Full Text] [Related]
5. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
[TBL] [Abstract][Full Text] [Related]
6. Proteome and miRNome profiling of microvesicles derived from medulloblastoma cell lines with stem-like properties reveals biomarkers of poor prognosis.
Kaid C; Assoni A; Marçola M; Semedo-Kuriki P; Bortolin RH; Carvalho VM; Okamoto OK
Brain Res; 2020 Mar; 1730():146646. PubMed ID: 31917138
[TBL] [Abstract][Full Text] [Related]
7. Quantitative proteomics identifies and validates urinary biomarkers of rhabdomyosarcoma in children.
Xu N; Yu Y; Duan C; Wei J; Sun W; Jiang C; Jian B; Cao W; Jia L; Ma X
Clin Proteomics; 2023 Mar; 20(1):10. PubMed ID: 36918772
[TBL] [Abstract][Full Text] [Related]
8. A Prognostic Methylation-Driven Two-Gene Signature in Medulloblastoma.
Michaelsen GL; da Silva LDRE; de Lima DS; Jaeger MDC; Brunetto AT; Dalmolin RJS; Sinigaglia M
J Mol Neurosci; 2024 Apr; 74(2):47. PubMed ID: 38662144
[TBL] [Abstract][Full Text] [Related]
9. LC-MS-Based Urine Metabolomics Analysis for the Diagnosis and Monitoring of Medulloblastoma.
Liu X; Li J; Hao X; Sun H; Zhang Y; Zhang L; Jia L; Tian Y; Sun W
Front Oncol; 2022; 12():949513. PubMed ID: 35936679
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid cytokines in metastatic group 3 and 4 medulloblastoma.
Low SYY; Bte Syed Sulaiman N; Tan EEK; Ng LP; Kuick CH; Chang KTE; Tang PH; Wong RX; Looi WS; Low DCY; Seow WT
BMC Cancer; 2020 Jun; 20(1):554. PubMed ID: 32539808
[TBL] [Abstract][Full Text] [Related]
11. Proteomic profiling of medulloblastoma reveals novel proteins differentially expressed within each molecular subgroup.
Narayan V; Jaiswal J; Sugur H; Sd S; Rao S; Chatterjee A; Gowda H; A A; Somanna S; Santosh V
Clin Neurol Neurosurg; 2020 Sep; 196():106028. PubMed ID: 32580068
[TBL] [Abstract][Full Text] [Related]
12. A systematic view of pediatric medulloblastoma proteomics-current state of the field and future directions.
Serra R; Mangraviti A
Childs Nerv Syst; 2021 Mar; 37(3):779-788. PubMed ID: 33409616
[TBL] [Abstract][Full Text] [Related]
13. Identification of Gravida Serum Biomarkers for Noninvasive Prenatal Diagnosis Fetal Congenital Heart Disease.
Xia Y; Cheng L; Duan J; Ma J; Zhang Y
J Cardiovasc Transl Res; 2023 Feb; 16(1):255-266. PubMed ID: 36178661
[TBL] [Abstract][Full Text] [Related]
14. Identification of noninvasive diagnostic biomarkers for hepatocellular carcinoma by urinary proteomics.
Zhao Y; Li Y; Liu W; Xing S; Wang D; Chen J; Sun L; Mu J; Liu W; Xing B; Sun W; He F
J Proteomics; 2020 Aug; 225():103780. PubMed ID: 32298775
[TBL] [Abstract][Full Text] [Related]
15. Using urinary bFGF and TIMP3 levels to predict the presence of juvenile pilocytic astrocytoma and establish a distinct biomarker signature.
Pricola Fehnel K; Duggins-Warf M; Zurakowski D; McKee-Proctor M; Majumder R; Raber M; Han X; Smith ER
J Neurosurg Pediatr; 2016 Oct; 18(4):396-407. PubMed ID: 27314542
[TBL] [Abstract][Full Text] [Related]
16. A proteomic analysis of urine biomarkers in autism spectrum disorder.
Wang Y; Zhang J; Song W; Tian X; Liu Y; Wang Y; Ma J; Wang C; Yan G
J Proteomics; 2021 Jun; 242():104259. PubMed ID: 33957315
[TBL] [Abstract][Full Text] [Related]
17. Urinary biomarker discovery in gliomas using mass spectrometry-based clinical proteomics.
Wu J; Zhang J; Wei J; Zhao Y; Gao Y
Chin Neurosurg J; 2020; 6():11. PubMed ID: 32922940
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation profiling is a method of choice for molecular verification of pediatric WNT-activated medulloblastomas.
Korshunov A; Sahm F; Zheludkova O; Golanov A; Stichel D; Schrimpf D; Ryzhova M; Potapov A; Habel A; Meyer J; Lichter P; Jones DTW; von Deimling A; Pfister SM; Kool M
Neuro Oncol; 2019 Feb; 21(2):214-221. PubMed ID: 30252101
[TBL] [Abstract][Full Text] [Related]
19. Differential urine proteome analysis of a ventilator-induced lung injury rat model by label-free quantitative and parallel reaction monitoring proteomics.
Qin W; Zhang X; Chen L; Li Q; Zhang B; Sun L; Han W
Sci Rep; 2021 Nov; 11(1):21446. PubMed ID: 34728735
[TBL] [Abstract][Full Text] [Related]
20. Two machine learning methods identify a metastasis-related prognostic model that predicts overall survival in medulloblastoma patients.
Chen K; Huang B; Yan S; Xu S; Li K; Zhang K; Wang Q; Zhuang Z; Wei L; Zhang Y; Liu M; Lian H; Zhong C
Aging (Albany NY); 2020 Nov; 12(21):21481-21503. PubMed ID: 33159021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
